Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BVGroup

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 3
Rounds per year 0.12
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Medical Device
  • Health Care
  • Information Technology
  • Medical
Summary

BVGroup appeared to be the Corporate Investor, which was created in 1997. The venture was found in Europe in Switzerland. The main department of described Corporate Investor is located in the Gu00fcmligen.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the BVGroup, startups are often financed by VI Partners AG, Novartis Venture Fund, Erfindungs Verwertung. The meaningful sponsors for the fund in investment in the same round are Venture Incubator, LLC, Novartis.

We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Covalys Biosciences, Anecova, Finox Biotech For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland.

The fund is constantly included in less than 2 deals per year. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this BVGroup works on 4 percentage points more the average amount of lead investments. The top amount of exits for fund were in 2016. The high activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BVGroup:
Typical Co-investors
BVGroup is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BVGroup:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
A&B (HK) -
Adelie France, Ile-de-France, Paris
BERRIUP Autonomous Community of the Basque Country, San Sebastián, Spain
Boyue Changxing Industrial China, Hubei, Wuhan Shi
Clare Island Media GmbH -
CR-CP Life Science Fund China, Hong Kong, Hong Kong Island
Crocker Mountain Capital -
DCVC Opportunity -
Ehime Bank Ehime Prefecture, Japan, Matsuyama
Inspovation Ventures California, Los Altos, United States
Jinsheng Capital -
MedImmune Louisiana, Maryland, United States
Playground Global California, Palo Alto, United States
Powe Capital Management England, London, United Kingdom
SK Holdings Seoul, Seoul-t'ukpyolsi, South Korea
Srijan Capital Bangalore, India, Karnataka
SSE Australia, Perth, Western Australia
Starstrike Ventures Berlin, Berlin, Germany
Zhejiang Zhuji Intelligent Security Industry Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Covalys Biosciences

Biotechnology
06 Mar 2006 Bern, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BVGroup?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 9M
Rounds per year 0.12
Peak activity year 2006
Lead investments 1
Exits 1
Group Appearance index 0.33

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Covalys Biosciences

Biotechnology
06 Mar 2006 Bern, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: